Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2018
EventASCO Annual Meeting - Chicago, IL
Duration: Jan 1 2018 → …

Conference

ConferenceASCO Annual Meeting
Period1/1/18 → …

Disciplines

  • Medicine and Health Sciences

Cite this